FlemingM, RivoM and KahnR. 1995. “Tobacco, Alcohol, and Drug Use in Primary Care: Prevalence, Treatment, and Costs”. In Training about Alcohol and Substance Abuse for All Primary Care Physicians, 175–290. New York: Josiah Macy Foundation.
2.
ReigerDA, FarmerMERaeDS. 1990. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA, 264: 2511–2518.
3.
CarrollK, NichC, BallSA, McCantsE and RounsavilleBJ. 1998. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction, 93: 713–728.
4.
SpitzerRL, WilliamsJBKroenkeK. 1994. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME–MD 1000 study. JAMA, 272: 1749–1756.
5.
LeonAC, OlfsonMWeissmanMM. 1996. Brief screens for mental disorders in primary care. J Gen Intern Med, 11: 426–430.
6.
American Psychiatric Association. 1995. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Washington, DC: American Psychiatric Association. Primary Care Version
7.
BeckAT, WardCH, MendelsonM, MockJ and ErbaughJ. 1961. An inventory for measuring depression. Arch Gen Psychiatry, 4: 461–471.
8.
HamiltonM. 1959. The assessment of anxiety states by rating. Br J Med Psychol, 32: 50–55.
9.
HamiltonM. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry, 23: 56–62.
10.
ZungWWK. 1965. A self–rating depression scale. Arch Gen Psychiatry, 12: 63–70.
11.
EwingJA. 1984. Detecting alcoholism: the CAGE questionnaire. JAMA, 252: 1905–1907.
12.
SelzerML. 1971. The Michigan Alcoholism Screening Test the quest for a new diagnostic instrument. Am J Psychiatry, 12: 89–94.
13.
NilssenO and HunterC. 1996. Screening patients for alcohol problems in primary health care settings. Am J Addict, 5(suppl): 3–8.
14.
MasonBJ. 1996. Dosing issues in the pharmacotherapy of alcoholism. Alcohol Clin Exp Res, 20: 10–16. Skinner, 1982
15.
MasonBJ. 1996. Dosing issues in the pharmacotherapy of alcoholism. Alcohol Clin Exp Res, 20: 10–16.
16.
McGrathPJ, NunesEVStewartJW. 1996. Imipramine treatment of alcoholics with primary depression: a placebo–controlled clinical trial. Arch Gen Psychiatry, 53: 232–240.
17.
CorneliusJR, SalloumIMEherJG. 1997. Fluoxetine in depressed alcoholics. A double–blind, placebo–controlled trial. Arch Gen Psychiatry, 54: 700–705.
18.
BradyKT, SonneSC, DanskyBS, RobertsJS and MalcolmRJ. 1998. Carbamazepine in cocaine–dependent individuals with affective disorder. Paper presented at: 60th Annual Scientific Meeting, College on Problems of Drug Dependence. 1998, Scottsdale, Ariz..
19.
KranzlerHR. 1996. Evaluation and treatment of anxiety symptoms and disorders in alcoholics. J Clin Psychiatry, 57: 15–21.
20.
BuckelyP, ThompsonP, WayL and MeltzerHY. 1994. Substance abuse among patients with treatment–resistant schizophrenia: characteristics and implications for clozapine therapy. Am J Psychiatry, 151: 385–389.
21.
SellersEM, HigginsGATompkinsDM. 1992. Serotonin and alcohol drinking. NIDA Res Monogr, 119: 141–145.
22.
StuartM and LiebermanJIII. 1993. The Fifteen–Minute Hour: Applied Psychotherapy for the Primary Care Physician, 2nd ed., Westport, Conn.: Praeger.
23.
MillerWR and RollnickS. 1991. Motivational Interviewing: Preparing People to Change Addictive Behavior, New York: Guilford Press.
24.
DaleyDC and ZuckoffA. 1998. Improving compliance with the initial outpatient session among discharged inpatient dual diagnosis clients. Soc Work, 43: 470–473.
25.
Alcoholics Anonymous. 1984. The AA Member: Medications and Other Drugs, New York: Alcoholics Anonymous World Services.
26.
RiesRK and ComtoisKA. 1997. Illness severity and treatment services for dually diagnosed severely mentally ill outpatients. Schizophr Bull, 23: 239–246.
27.
BradyKT, SelanderJ, AntonR, LydiardRB, AdinoffB and BallengerJC. 1990. Cocaine abuse in schizophrenia. Am J Psychiatry, 147: 1146–1167.
28.
SonneSC, BradyKT and MortonWA. 1994. Substance abuse and bipolar affective disorder. J Nerv Ment Dis, 182: 349–352.